Form 4: Intellicheck CEO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Intellicheck CEO Bryan Lewis sold 10,000 shares of common stock through a pre-arranged trading plan, with the sale executed on April 13, 2026.

Summary

  • Bryan Lewis, CEO and President of Intellicheck, Inc. (IDN), reported a transaction involving the sale of 10,000 shares of common stock.
  • The transaction occurred on April 13, 2026, and the sale price was $7.9503 per share.
  • These shares were owned by The Lewis Family Revocable Living Trust.
  • The sale was executed under a Rule 10b5-1 trading plan, which was adopted on December 17, 2025.
  • The trading plan had a selling start date of April 6, 2026, and an end date of July 31, 2026.
  • Following this transaction, the reporting person's beneficial ownership of common stock is 60,000 shares, held indirectly through the trust.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative event due to the insider sale, although the use of a 10b5-1 plan mitigates concerns about opportunistic trading.

Negatives

  • CEO sold a significant number of shares (10,000) which could be perceived negatively by the market.

Risks

  • The sale of shares by a CEO, even under a 10b5-1 plan, can sometimes be interpreted as a lack of confidence in the company's future prospects by investors.
  • The Rule 10b5-1 plan has an end date of July 31, 2026, implying potential for further sales within this period.

Future Outlook

The Rule 10b5-1 trading plan is active until July 31, 2026, indicating that further transactions may occur within this period as per the plan's parameters.

Management Comments

  • Mr. Lewis disclaims beneficial ownership of these shares other than to the extent of his pecuniary interest therein, if any.

Industry Context

StockSavvy.ai notes that insider sales, even those conducted under Rule 10b5-1 plans, are closely monitored by investors as they can signal management's perception of the company's valuation and future prospects. Such transactions are common for executives to diversify their holdings or meet financial obligations.

Stakeholder Impact

  • Shareholders: May interpret the CEO's sale as a negative signal, potentially impacting share price, despite the 10b5-1 plan.
  • Management: The transaction is a standard part of executive financial planning and diversification.

Next Steps

  • Monitoring of any further transactions under the Rule 10b5-1 plan until its end date of July 31, 2026.

Key Dates

DateDescription
12/17/2025Adoption date of the Rule 10b5-1 trading plan by The Lewis Family Revocable Living Trust.
04/06/2026Selling Start Date for the Rule 10b5-1 trading plan.
04/13/2026Transaction date for the sale of 10,000 shares of common stock.
04/14/2026Date of the signature on the Form 4 filing.
07/31/2026Plan End Date for the Rule 10b5-1 trading plan.

Recommendation

hold

The sale of shares by the CEO, while executed under a pre-defined 10b5-1 plan, warrants a 'hold' recommendation. Investors should monitor future filings for any additional sales and the company's overall performance, as insider selling can sometimes precede price declines. The existence of the 10b5-1 plan suggests the sale is not based on immediate non-public information, but it still represents a reduction in insider ownership.

Keywords

Intellicheck, IDN, Form 4, Insider Trading, SEC Filing, Stock Sale, CEO, Bryan Lewis, Rule 10b5-1, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.